Tag: FDA

FDA drafting protocols to track COVID-19 vaccine safety

Editor's Note The Food and Drug Administration’s (FDA’s) Office of Biostatistics and Epidemiology is currently developing master protocols to be used in monitoring the safety and effectiveness of a COVID-19 vaccine once it is authorized or approved, in addition to postmarket surveillance requirements, the October 22 Regulatory Focus reports. The…

Read More

By: Judy Mathias
October 27, 2020
Share

ECRI warns of fast-tracking COVID-19 vaccines

Editor's Note ECRI announced October 21 that its President and CEO, Marcus Schabacker, MD, PhD, will tell the Food & Drug Administration Vaccines and Related Biological Products Advisory Committee on October 22 that a thorough review of 6 months of completed clinical trial data for COVID-19 vaccines is needed to…

Read More

By: Judy Mathias
October 22, 2020
Share

FDA reissues EUA for N95 respirators manufactured in China

Editor's Note The Food and Drug Administration (FDA) on October 15 announced that it reissued the Emergency Use Authorization (EUA) for certain N95 and other filtering face-piece respirators that are manufactured in China and are not approved by the Centers for Disease Control and Prevention’s National Institute for Occupational Safety…

Read More

By: Judy Mathias
October 19, 2020
Share

FDA issues guidance on EUA for COVID-19 vaccines

Editor's Note The Food and Drug Administration (FDA) on October 6 released guidance on the data and information needed to support the issuance of emergency use authorization (EUA) for COVID-19 vaccines. The recommended data and information include: chemistry, manufacturing, and controls information clinical and nonclinical data and information administration and…

Read More

By: Judy Mathias
October 8, 2020
Share

HHS renews public health emergency for COVID-19

Editor's Note Secretary of Health and Human Services (HHS), Alex Azar, on October 2, renewed the national public health emergency (PHE) for COVID-19 for another 90 days. The renewal will take effect October 23. This is the third renewal of PHE, which has been in effect since late January. The…

Read More

By: Judy Mathias
October 6, 2020
Share

FDA warns about hand sanitizers packaged in food, drink containers or containing methanol

Editor's Note The Food & Drug Administration (FDA) on August 27 (updated September 2) issued a warning about alcohol-based hand sanitizers packaged in containers that may appear as food or drinks and could put consumers at risk of serious injury or death if ingested.( https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-warns-consumers-about-hand-sanitizer-packaged-food-and-drink-containers ) Some hand sanitizers are…

Read More

By: Judy Mathias
October 1, 2020
Share

HHS, DOD outline COVID-19 vaccine distribution strategy

Editor's Note The US Department of Health and Human Services (HHS) and Department of Defense (DOD) on September 16 released two documents outlining a detailed strategy for delivering safe and effective COVID-19 vaccine doses to the American people as quickly and reliably as possible. The documents, which were developed in…

Read More

By: Judy Mathias
September 17, 2020
Share

Fauci says COVID-19 vaccine trials could end early if results are overwhelmingly positive

Editor's Note Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health told the Kaiser Health News on September 1 that a COVID-19 vaccine could be available earlier than expected if clinical trial results are overwhelmingly positive. An independent Data and…

Read More

By: Judy Mathias
September 3, 2020
Share

FDA could fast-track COVID-19 vaccine approval

Editor's Note In an interview with the Financial Times, Food & Drug Administration (FDA) Commissioner Stephen Hahn, MD, on August 30, said the FDA could fast-track approval of a COVID-19 vaccine before late-stage clinical trials are complete if regulators believe the benefits of doing so outweigh the risks. Dr Hahn…

Read More

By: Judy Mathias
August 31, 2020
Share

FDA warns against use of protective barrier enclosures without negative pressure during intubation, extubation of COVID-19 patients

Editor's Note In an August 21 letter, the Food & Drug Administration (FDA) warns that the use of passive protective barrier enclosures without negative pressure when treating patients (such as during intubation, extubation) who are known or suspected to have COVID-19 may pose increased health risk to patients and healthcare…

Read More

By: Judy Mathias
August 26, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat